Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells - Wikidata - awgldk - TriplyDB

Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells

Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells

http://www.wikidata.org/entity/Q24548940

about

Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy Targeted DNA mutagenesis for the cure of chronic viral infections Animal Models for HIV Cure Research Redefining the viral reservoirs that prevent HIV-1 eradication HIV-1 eradication strategies: design and assessment The immunological synapse: the gateway to the HIV reservoir Recent developments in human immunodeficiency virus-1 latency research New tools for quantifying HIV-1 reservoirs: plasma RNA single copy assays and beyond Persistence of viral reservoirs in multiple tissues after antiretroviral therapy suppression in a macaque RT-SHIV model Targeting the Brain Reservoirs: Toward an HIV Cure ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia HIV-1 infection of bone marrow hematopoietic progenitor cells and their role in trafficking and viral dissemination Bryostatin modulates latent HIV-1 infection via PKC and AMPK signaling but inhibits acute infection in a receptor independent manner Dynamics of HIV-1 quasispecies during antiviral treatment dissected using ultra-deep pyrosequencing Episomal viral cDNAs identify a reservoir that fuels viral rebound after treatment interruption and that contributes to treatment failure Deep molecular characterization of HIV-1 dynamics under suppressive HAART Reappearance of minority K103N HIV-1 variants after interruption of ART initiated during primary HIV-1 infection Residual viremia in an RT-SHIV rhesus macaque HAART model marked by the presence of a predominant plasma clone and a lack of viral evolution Real-Time Predictions of Reservoir Size and Rebound Time during Antiretroviral Therapy Interruption Trials for HIV Residual Viremia in Treated HIV+ Individuals Review: Influence of ART on HIV genetics Eradication therapies for HIV Infection: time to begin again.HIV pathogenesis: dynamics and genetics of viral populations and infected cells.Romidepsin-induced HIV-1 viremia during effective ART contains identical viral sequences with few deleterious mutations.Designed, synthetically accessible bryostatin analogues potently induce activation of latent HIV reservoirs in vitro The Role of Caveolin 1 in HIV Infection and Pathogenesis.Limits on replenishment of the resting CD4+ T cell reservoir for HIV in patients on HAART Low-level HIV-1 replication and the dynamics of the resting CD4+ T cell reservoir for HIV-1 in the setting of HAART.Serial evolutionary networks of within-patient HIV-1 sequences reveal patterns of evolution of X4 strains.CpG methylation controls reactivation of HIV from latency.Evidence for limited genetic compartmentalization of HIV-1 between lung and blood Compartmentalization of HIV-1 within the female genital tract is due to monotypic and low-diversity variants not distinct viral populations.Modeling latently infected cell activation: viral and latent reservoir persistence, and viral blips in HIV-infected patients on potent therapy.HIV-1 residual viremia correlates with persistent T-cell activation in poor immunological responders to combination antiretroviral therapy.Cellular levels of HIV unspliced RNA from patients on combination antiretroviral therapy with undetectable plasma viremia predict the therapy outcome Restriction of HIV-1 genotypes in breast milk does not account for the population transmission genetic bottleneck that occurs following transmission Immunotoxin complementation of HAART to deplete persisting HIV-infected cell reservoirs Viral sanctuaries during highly active antiretroviral therapy in a nonhuman primate model for AIDS A spatio-temporal assessment of simian/human immunodeficiency virus (SHIV) evolution reveals a highly dynamic process within the host.Proteomic analysis of HIV-infected macrophages

P2860

Q22251085-E5617743-35DA-4E15-907D-793F956D6799 Q24620150-B9926E9E-4B87-41B8-8809-E5B9A1153C06 Q26767476-333D9E9D-E524-4D40-8FEA-C6FCDB952A54 Q26827255-71173704-EFB7-430E-8726-17FACDB8F9D7 Q26864933-0B67DA56-017A-4CBA-9663-3A92AF6C7645 Q27002959-72977A61-AF9B-4314-8003-E446E4BFAA46 Q27013114-EFD4E914-7C18-4A2E-AAD6-E531BC53DB71 Q27027164-E527A3DC-86AE-4A60-AE4A-F83C1A545CDE Q27335485-8541ADFF-78A8-4E8D-BE47-8FF730CF3FBA Q28075694-3F565EC9-025C-408C-9DF0-FCE3B5545357 Q28469175-A4060FD8-1A7B-44ED-B032-416536F07578 Q28474374-7D1002C4-5258-4201-8A17-7AB3E5D13AE5 Q28474468-943A30C0-E3C6-4FEA-8F66-7662AD56E2FD Q28474783-017BCE19-9F2E-49CA-A2FC-141DCCFB97F3 Q28477257-8F6E66ED-3550-4240-9638-A7770C8951D6 Q28477677-81B033BD-206F-4052-A14B-9B212E102AF9 Q28478934-4FA5401C-FB23-493B-890A-5D43FAC0A57D Q28539563-38F7FB09-8A25-4772-B75D-BC4BE706225B Q28551642-1A676A47-6427-4385-8CD0-BAFAF3BDF8DB Q28552126-7B536886-3C8E-40A7-8839-55A234DD1926 Q28649848-4C51D754-EFF6-43C2-B748-B4FE9083C502 Q30399588-07DB5F4C-52BD-4A65-A9F6-98D10419F681 Q30425443-9F92A297-AA6E-4DA2-A75C-C0355E5AF20A Q30490742-38D5DC3D-A839-4616-8FBF-6022FAE20681 Q30558754-16AF009D-F4CE-40F2-94B8-D0302F31298F Q32183747-E173BAD6-9DC0-445C-9EF8-E6C0A7D17E52 Q33296883-C4C916E6-E173-4E35-BE99-8E691A5F7B88 Q33313038-725183F8-B782-4C29-9C0A-124C48627C03 Q33468625-64DD2541-A1F1-46B0-8F60-6E27CAFCA564 Q33495565-A06E6E7A-9401-4A71-B371-DB937665D928 Q33504173-2900D950-742A-4468-ABBE-4DEAD6F25458 Q33505667-540E1011-7B81-4384-9B52-49A13F87B1D8 Q33510903-49A1B219-F085-4D95-8578-6164AF35E3CB Q33513977-14E11D96-DAE5-493C-A7A6-4D6F7E5612C0 Q33521702-3FFCEE87-86E1-4A3D-AD02-2D07C676E287 Q33565651-5B66EFE9-CE74-455D-96A0-2A9AB930E5AC Q33604776-063C70F2-3CC4-418C-9149-3049259C9B87 Q33676630-4888FD05-F65F-4C21-9A56-8CA66A1ED37B Q33728690-BEE5FF32-8CC9-424F-8F9F-A1A618B70E8E Q33770687-5AEEA7D0-5D76-4F54-89E1-E134146C3E4A

P2860

Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells

http://www.wikidata.org/entity/Q24548940

description

2006 nî lūn-bûn

@nan

2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Residual human immunodeficienc ...... nd in circulating CD4+ T cells

@ast

Residual human immunodeficienc ...... nd in circulating CD4+ T cells

@en

Residual human immunodeficienc ...... nd in circulating CD4+ T cells

@nl

type

label

Residual human immunodeficienc ...... nd in circulating CD4+ T cells

@ast

Residual human immunodeficienc ...... nd in circulating CD4+ T cells

@en

Residual human immunodeficienc ...... nd in circulating CD4+ T cells

@nl

prefLabel

Residual human immunodeficienc ...... nd in circulating CD4+ T cells

@ast

Residual human immunodeficienc ...... nd in circulating CD4+ T cells

@en

Residual human immunodeficienc ...... nd in circulating CD4+ T cells

@nl

P1433

Q24548940-8BD690E0-355A-43F3-ABA5-94864088D30B

P1476

Q24548940-C1364F11-246C-495F-BC66-36D95FFCAC66

P2093

Q24548940-29FC1DB1-4E16-4319-BD76-062399BB4324

Q24548940-36F3326A-FA6E-4177-85CD-17A472A1EF34

Q24548940-38C7227F-2E50-483D-B52C-8C9E405E389C

Q24548940-79C8769D-B97F-46DB-BE18-C37C83A975F7

Q24548940-80EDF3BA-5E2A-4538-B2AF-D87D674A2BA0

Q24548940-85E849E1-3779-4A2B-BD15-BA97125F0FAB

Q24548940-88BC1E0B-BF99-46E8-B18B-0A74E5932736

Q24548940-8A349C05-8B1A-4FEC-A4AA-6247CDDE2403

Q24548940-B939445C-01C5-47BD-B7E7-22342744A926

Q24548940-CC72C8D0-B759-4D65-85C0-1D9569B6F740

P2860

Q24548940-0A5168A7-A634-4DC9-8C10-467CF48E9CA8

Q24548940-0D066F67-B697-4EA9-8465-4E2B40778CC2

Q24548940-0FA52A8A-717A-4A38-B2EB-40C8AAC6B4AB

Q24548940-12C069AD-C4D6-4EA8-A5EF-B3518FEE7255

Q24548940-1BEB9C6E-8189-4044-A76C-7D1A700B9F52

Q24548940-1E14E3B3-AE4F-4A59-94C3-25EF93FAE32B

Q24548940-247D7AC3-22B3-4E1B-85C2-9F7CFBDC2420

Q24548940-322B5D9D-BDE9-480D-A58B-108C6BB1A43C

Q24548940-32D562DB-DC7B-47ED-AFB3-5912425B63B5

Q24548940-36796237-C184-46B8-B708-31939AFB4A79

P304

Q24548940-3E847162-2A2A-43C7-B87D-F5669039474B

P31

Q24548940-F8596710-A88B-455C-B5C8-5F2A48C7217A

P3181

Q24548940-5A745053-29FA-412A-A0FA-D363A9D9CEEE

P356

Q24548940-A2416DE8-26E2-4764-B4D5-F83410EC67C6

P407

Q24548940-94C82122-070C-4EDA-8950-8FB168E3119D

P433

Q24548940-6A5A8FAF-E985-4D91-8748-8DD0CBFB4522

P478

Q24548940-1E332ABE-1099-4D5F-A0D8-2E9A21D9CD09

P50

Q24548940-569E5910-3CEA-4314-863E-92082C596B06

Q24548940-655140AF-5F7B-447A-A3E1-BC4FDCFF9F04

Q24548940-7A8B1714-04A4-4491-A32A-A370BB0BD347

Q24548940-96E3AAE0-7D72-4D96-945C-5AE7B0C25A0B

Q24548940-B0E29362-F582-4CC9-8B18-0A7B3242D843

Q24548940-C5D76BEB-C873-4367-9304-84ECCA903193

P577

Q24548940-669329CE-C45D-407D-A47B-4E7FB06E6CA9

P698

Q24548940-514C0367-6FD1-499D-882E-22F751629818

P921

Q24548940-3271F26A-A04A-4196-B1D7-2A2871E385E2

Q24548940-37DCAF3B-A6A7-470B-ABAB-E4BE9FF43FAA

P932

Q24548940-995B6B3E-5F68-4BA0-B919-4451C92A9BD5

P3181

P356

P1433

Journal of Virology

P1476

Residual human immunodeficienc ...... nd in circulating CD4+ T cells

@en

P2093

Ahmad R Sedaghat

http://www.w3.org/2001/XMLSchema#string

Ashrit R Kamireddi

http://www.w3.org/2001/XMLSchema#string

Christine M Haggerty

http://www.w3.org/2001/XMLSchema#string

Deborah Persaud

http://www.w3.org/2001/XMLSchema#string

Janet D Siliciano

http://www.w3.org/2001/XMLSchema#string

Jessica Lee

http://www.w3.org/2001/XMLSchema#string

Joel E Gallant

http://www.w3.org/2001/XMLSchema#string

Joseph Cofrancesco

http://www.w3.org/2001/XMLSchema#string

Justin R Bailey

http://www.w3.org/2001/XMLSchema#string

Megan Wind-Rotolo

http://www.w3.org/2001/XMLSchema#string

P2860

MODELTEST: testing the model of DNA substitution

TreeView: an application to display phylogenetic trees on personal computers

Depletion of latent HIV-1 infection in vivo: a proof-of-concept study

Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

Viral dynamics in human immunodeficiency virus type 1 infection

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

P304

6441-57

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2056615

http://www.w3.org/2001/XMLSchema#string

P356

10.1128/JVI.00591-06

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

80

http://www.w3.org/2001/XMLSchema#string

P50

Yi Liu-Chittenden

Megan Wind-Rotolo

Robert F. Siliciano

P577

2006-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16775332

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

1488985

http://www.w3.org/2001/XMLSchema#string